Task: Answer the multiple choice question.
Question: Which drug exhibits a 10.540\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a. CCN1CCN(Cc2c(C)[nH]c3ccc(OC)cc3c2=O)CC1
b. CN(C)c1c(F)cc(C(=O)NC(=O)NCc2cccnc2)cc1F
Answer: b. CN(C)c1c(F)cc(C(=O)NC(=O)NCc2cccnc2)cc1F
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CN(C)c1c(F)cc(C(=O)NC(=O)NCc2cccnc2)cc1F
CN(C)c1c(F)cc(C(=O)NC(=O)NCc2cccnc2)cc1F
4-(dimethylamino)-3,5-difluoro-N-(pyridin-3-ylmethylcarbamoyl)benzamide